Three reports evaluating four PD-L1 IHC assays in NSCLC tumor cells suggest good concordance between the Ventana SP263, Dako 28-8, and Dako 22C3 assays, whereas SP142 was found to be less sensitive [21,22,23]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.